Akums Drugs and Pharmaceuticals Limited (BOM:544222)

BOM:544222 Statistics

Total Valuation

BOM:544222 has a market cap or net worth of INR 85.98 billion. The enterprise value is 81.27 billion.

Market Cap	85.98B
Enterprise Value	81.27B

Important Dates

The last earnings date was Tuesday, June 17, 2025.

Earnings Date	Jun 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	153.10M
Shares Outstanding	n/a
Shares Change (YoY)	+4.58%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	23.12M

Valuation Ratios

The trailing PE ratio is 25.43 and the forward PE ratio is 24.92.

PE Ratio	25.43
Forward PE	24.92
PS Ratio	2.09
PB Ratio	2.81
P/TBV Ratio	2.83
P/FCF Ratio	44.58
P/OCF Ratio	18.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.31, with an EV/FCF ratio of 42.13.

EV / Earnings	24.03
EV / Sales	1.97
EV / EBITDA	17.31
EV / EBIT	25.52
EV / FCF	42.13

Financial Position

The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.03.

Current Ratio	2.55
Quick Ratio	1.51
Debt / Equity	0.03
Debt / EBITDA	0.19
Debt / FCF	0.46
Interest Coverage	10.47

Financial Efficiency

Return on equity (ROE) is 18.17% and return on invested capital (ROIC) is 8.97%.

Return on Equity (ROE)	18.17%
Return on Assets (ROA)	5.22%
Return on Invested Capital (ROIC)	8.97%
Return on Capital Employed (ROCE)	9.89%
Revenue Per Employee	5.47M
Profits Per Employee	448,747
Employee Count	7,536
Asset Turnover	1.08
Inventory Turnover	3.81

Taxes

In the past 12 months, BOM:544222 has paid 14.76 million in taxes.

Income Tax	14.76M
Effective Tax Rate	0.43%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	559.75
200-Day Moving Average	602.83
Relative Strength Index (RSI)	50.00
Average Volume (20 Days)	17,496

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:544222 had revenue of INR 41.21 billion and earned 3.38 billion in profits. Earnings per share was 22.60.

Revenue	41.21B
Gross Profit	16.22B
Operating Income	3.18B
Pretax Income	3.45B
Net Income	3.38B
EBITDA	4.57B
EBIT	3.18B
Earnings Per Share (EPS)	22.60

Balance Sheet

The company has 5.76 billion in cash and 882.12 million in debt, giving a net cash position of 4.88 billion.

Cash & Cash Equivalents	5.76B
Total Debt	882.12M
Net Cash	4.88B
Net Cash Per Share	n/a
Equity (Book Value)	30.64B
Book Value Per Share	199.02
Working Capital	13.81B

Cash Flow

In the last 12 months, operating cash flow was 4.65 billion and capital expenditures -2.72 billion, giving a free cash flow of 1.93 billion.

Operating Cash Flow	4.65B
Capital Expenditures	-2.72B
Free Cash Flow	1.93B
FCF Per Share	n/a

Margins

Gross margin is 39.35%, with operating and profit margins of 7.73% and 8.21%.

Gross Margin	39.35%
Operating Margin	7.73%
Pretax Margin	8.38%
Profit Margin	8.21%
EBITDA Margin	11.08%
EBIT Margin	7.73%
FCF Margin	4.68%

Dividends & Yields

BOM:544222 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.58%
Shareholder Yield	n/a
Earnings Yield	3.93%
FCF Yield	2.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BOM:544222 has an Altman Z-Score of 8.55 and a Piotroski F-Score of 6.

Altman Z-Score	8.55
Piotroski F-Score	6